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MEDICAL APPROACH TO THE DIAGNOSIS OF KIDNEY STONES*
BOY FR.\ME,

M.D.**

A gratifying experience in the professional life of a physician is that of detecting
an underiying metabolic disorder in a patient with kidney stones. It is especially
satisfying if the defect can be corrected and the recurrence of kidney stones thereby
prevented.
When a patient with a kidney stone is first seen, it is often difficult to decide
on the extent of the initial medical evaluation. Many patients pass but one stone
in a lifetime and in this instance detailed investigation hardly seems warranted.
However, when the patient is first seen it is not known whether or not that particular
patient will be the one to have recurrent stone formation. Perhaps at the time of
the next patient contact urinary tract infection, renal insufficiency, or both, will be
present which will complicate metabolic study and treatment.
What are the diagnostic steps from the metabolic point of view in a patient
with recurrent nephrolithiasis? Certainly the kidney stone should be obtained if at
all possible for crystal analysis. Unfortunately padents will often have an extensive
metabolic investigation and the physician later learns that the patient has his kidney
stone at home in a dresser drawer as a souvenir.
Numerous techniques are available for stone analysis. Only the quality of crystal
present in the stone is important, not the quantity. It must be remembered that
kidney stones may be laminated and that the stone nucleus alone may harbor the
clue to the basic metabolic error. With experience many stones can be identified by
the naked eye with the aid of a hand lens. The spiked calcium oxalate stone which
may be particularly painful is quite characteristic. Distinct and multiple laminations
may give a clue to the presence of calcium phosphate stones. The cysUne stone
is smooth in outline, waxey in appearance and homogeneous in texture. Chemical
spot tests of either the urine or urinary sediment are available for crystal identification.
Microscopic examination of the urinary sediment may be of help but may also be
misleading. The hexagonal crystals of cystine are most distinctive and unforgetable
once observed under the microscope. It must be remembered that the crystal identified
*Address given at the Fourth Annual Michigan Kidney Disease Symposium, June 4-5th, Flint,
Michigan.
**Fifth Medical Division.
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in the urinary sediment may not be the same crystal present in the kidney stone,
itself. This is especially true after various forms of treatment have been initiated
that predispose to crystal formation different from that originally present.
In some institutions polarized microscopy and x-ray diffraction are used for
crystal identification but require special equipment and considerable experience. At
the Henry Ford Hospital we are fortunate in having Mr. Parsons of the Physics
Department who has analyzed approximately 1200 kidney stones for crystal structure
by x-ray diffraction. With his techniques and experience he is able to give a prompt
report of the crystal structure in kidney stones as well as in other body concretions.
Many times he has given a correct lead to the underlying metabolic defect, particularly
with regards to cystine stones. For practical purposes stone analysis should inform the
physician whether he is basically dealing with a defect in calcium, cystine or uric
acid metabolism. The situation may be complicated in those patients who- pass stones
containing several different types of crystals. For instance, a patient initially may
have passed a uric acid or cystine stone, but after treatment with urinary alkalinization
superimposed calcium stones may form.
CALCIUM-CONTAINING STONES

In temperate United States calcium-containing kidney stones present the greatest
difficulty in diagnosis and treatment. The important first step in evaluating the patient
with a calcium stone is to determine whether or not hypercalcemia is present. The
serum calcium determination and its clinical interpretation is fraught with many errors
and difficulties. Hospital laboratories in general do less than an ideal job in the accurate
determination of the total serum calcium. Solutions of known calcium composition
have been sent as unknowns to laboratories in community hospitals and the values
obtained have ranged up to 100% in error.' The normal range and standard deviation
should be defined for each hospital laboratory. This is not easy because it is not
always certain that supposed normal controls do, indeed, have normal serum calcium
levels. Nevertheless, each laboratory should periodically insert a series of so-called
normal serum samples for calcium determination in an attempt to keep a check on
standards and normal values. There is no data as to whether a diurnal variation in
the level of serum calcium exists; if it occurs, it must be of a minor degree. In normal
subjects, a reduction in oral calcium intake for several days will result in a slight
but significant depression of the mean serum calcium.^ Also, after the ingestion of
several glasses of milk, the serum calcium may be slightly increased. It is, therefore,
important to obtain the serum calcium when patients have been on an average
calcium intake and also when in the fasting state. A difference of .2 to .3 mgm%
can be important when one is evaluating patients with borderline hyper- or hypocalcemia.
With most methods, a value over 10.5 mgm% should be suspect for hypercalcemia.
There is evidence to suggest that climate may affect levels of serum calcium.
In a recent study' serum calcium and also serum phosphorus and antirachitic
levels were found to average higher in Puerto Rican than in Michigan women,
perhaps a reflection of greater exposure to sunshine in the former. It is also possible
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that serum calcium levels are normally higher during the summer months than in the
winter. This has previously been shown to be true in patients with sarcoid who are
thought to be unduly sensitive to the hypercalcemic action of vitamin D.
Prolonged venous stasis and vigorous forearm exercise during venipuncture have
also been shown to increase the level of serum calcium to a significant degree.'' This
occurs since protein free plasma is lost from the occluded vein resulting in a relative
increase in plasma proteins to which calcium is bound. It is, therefore, important
that technicians be instructed to keep the arm tourniquet on as briefly as possible
and to have the patient refrain from using vigorous forearm contraction during
the venipuncture. I t has also recently been determined that the serum calcium value
may be increased when the serum is allowed to come in contact with cork stoppers.^
Therefore, rubber stoppers are recommended, especially when samples are mailed
and the serum inadvertently is in contact with the stopper for long periods of time.
Physicians seldom reflect on the complexity of the calcium fractions when
ordering a serum calcium. The non-filterable calcium accounting for approximately
45% of the total serum calcium is bound primarily to albumin and, to a lesser
extent, to various globulins. The ultrafilterable fraction, including complexed calcium,
accounts for approximately 55%.' A reduction in serum albumin for any reason
is one of the most common causes of a depressed total serum calcium. Under these
circumstances, tetany is seldom present since the concentration of ionic calcium is usually
maintained. A n elevation of the total serum calcium does not normally occur as a
result of increased protein binding that might occur in various hypergammaglobulinemic
states such as sarcoidosis and multiple myeloma. The hypercalcemia here is due to
other mechanisms. Complexing of serum calcium to bicarbonate, citrate, phosphate
and other ions accounts for a relatively small portion of the total serum calcium and
ordinarily is not of clinical importance. However, in renal insufficiency, the complexed
fraction may be increased, primarily because of binding with sulphates and phosphates.
There have been numerous attempts to improve the significanse of the serum
calcium value by fractionation into its various components. Determination of the
ionic fraction is too difficult for most general hospital laboratories and has not as
yet been proved more helpful than the determination of the total serum calcium
alone in the evaluation of hypercalcemic states. A recent study of 166 serum
ultrafilterable calcium determinations in 150 individuals showed nO' constant deviations
of diagnostic significance in patients with malignancies, hyperparathyroidism, hypoparathyroidism, multiple myeloma, sarcoidosis, connective tissue disorders, muscle
dystrophy, vitamin D resistant rickets and osteoporosis.' The total serum calcium,
therefore, if done accurately, is sufficient in evaluation of hypercalcemic states.
Once definite hypercalcemia has been established in a patient with nephrolithiasis,
many underlying diseases need be considered. Table I lists the more common conditions
giving rise to hypercalcemia which may be accompanied by nephrolithiasis.
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Table I
Causes of Hypercalcemia and Nephrolithiasis
1. Hyperparathyroidism
2.

Sarcoidosis

3. Malignancy, myeloma
4.

Hypervitaminosis D

6. Immobilization
a) Osteoporosis
b) Paget's disease
7. Milk alkali syndrome
The diagnosis of hyperparathyroidism is largely a diagnosis of exclusion since
there is no specific laboratory proof. If other causes of hypercalcemia can be excluded
in a patient with nephrolithiasis, hyperparathyroidism is the most likely diagnosis.
The presence of hypercalcemia in a patient with sarcoidosis or thyrotoxicosis does
not automatically exclude hyperparathyroidism. There are numerous case reports in
the literature where hyperparathyroidism has been present in conjunction with other
hypercalcemic conditions. While hypercalcemia is common in malignancy, myeloma
and thyrotoxicosis, nephrolithiasis appears rarely in these conditions. Perhaps this
is a reflection of the short life expectancy in most patients with malignancy and the
early diagnosis usually made in thyrotoxicosis.
The serum inorganic phosphrous is of relatively little value in the differential
diagnosis of hypercalcemia and nephrolithiasis. As with the determination of serum
calcium, its accuracy and proper evaluation is fraught with pitfalls. Dietary restriction
of phosphorus will result in a depression of the fasting serum inorganic phosphorus.
The administration of nonabsorbable alkalis will also lower the serum phosphorus
and is one of the most common causes of hypophosphatemia in patients with dyspepsia
and peptic ulcer. While classically the serum inorganic phosphorus is depressed in
hyperparathyroidism, a normal or even increased value is fully compatible with the
condition, especially in the presence of renal insufficiency. Hypophosphatemia may
occur in almost all other hypercalcemic states and is not particularly helpful in differentiating hyperparathyroidism from other causes of hypercalcemia. It is to be remembered that the serum inorganic phosphorus is ordinarily higher in infants and
also in postmenopausal women.
Many other laboratory tests and procedures have been utilized in the evaluation
of patients with calcium-containing stones. The serum protein electrophoresis is
helpful in excluding myeloma and sarcoidosis. The serum alkaline phosphatase may
be elevated in most conditions giving rise to hypercalcemia and, therefore, is of little
help except in association with subpereosteal resorption when it supports the diagnosis
of hyperparathyroidism. In the differential diagnosis of hypercalcemic states, the
cortisone tolerance test may be helpful. When cortisone is administered in the dose
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of 150 mgm. a day for ten days, the serum calcium will frequentiy return to normal
in sarcoid, hypervitaminosis D and in many malignant states. The hypercalcemia of
hyperparathyroidism, on the other hand, is generally unaffected by such a course
of corticosteroids, but exceptions have been noted.
During the past few years many attempts have been made to utilize the phosphaturic effects of parathyroid hormone in the diagnosis of hyperparathyroidism. The
percent tubular reabsorption of phosphorus (%TRP), phosphate clearance (Cp) and
the phosphate excretion index (PEI) popularized by various authors have been attempts
at improving this diagnostic approach. Interested physicians in most clinics have
lost enthusiasm for these tests since they are not specific and both false positive
and false negative results have been reported. They have never been especially
helpful to us in the diagnosis of any patient with hyperparathyroidism, and we now
use them only in borderline cases and only in conjunction with the total clinical and
laboratory information.
Various calcium infusion tests have also been developed in an attempt to improve
diagnosis in hyperparathyroid states. These tests are based on the theory that intravenous calcium inhibits synthesis and release of parathyroid hormone, thereby
reducing urinary phosphorus excretion. Supposedly in the patient with an autonomous
parathyroid adenoma, calcium infusion is unable to effect parathyroid hormone
release. Under these circumstances, urinary phosphorus either remains the same
or may be increased. Goldsmith has developed a four hour test utilizing calcium
infusion while measuring the effect on the phosphate-creatinine excretion ratio
in the urine. In his experience this ratio is normally reduced during the second
hour after calcium infusion but is increased in patients with hyperparathyroidism.
With the use of his infusion test. Goldsmith has diagnosed hyperparathyroidism in
patients with nephrolithiasis, even in the absence of hypercalcemia. We have observed
both false positive and false negative results with calcium infusion tests which reduces
their value in diagnosis. There is recent evidence to suggest that calcium infusion
may influence the renal excretion of phosphorus, even in the absence of the parathyroid
glands which, if true, would weaken the physiologic basis for the test. It is also
to be remembered that the parathyroid glands should theoretically be suppressed in
other hypercalcemic states. Under these circumstances calcium infusion may not
affect the already suppressed parathyroid glands and resuUs similar to those expected
in hyperparathyroidism may be observed. In other words, the calcium infusion test
does not idfferentiate hyperparathyroidism from other hypercalcemic states.
There have been exciting new advances in methods to assay blood levels of
parathyroid hormone. Radioimmunoassay techniques at the present time are being
improved and soon may be sensitive enough to be of greater help in the diagnosis
of hyperparathyroidism. Insulin and growth hormone appear to be better antigenic
stimuli than parathyroid hormone and presently assays for these hormones are approximately 5 times as sensitive as that for parathormone. New advances in this
area of diagnosis are expected soon.
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HYPERCALCIURIA AND NEPHROLITHIASIS

When hypercalcemia has been ruled out in a patient with a calcium-containing
kidney stone, an attempt should be made to evaluate the presence of hypercalciuria.
Renal excretion of calcium is complex and some of the important factors are only
beginning to be understood.
The level of ultrafilterable serum calcium and the glomerular filtration rate
determine the concentration of calcium in the glomerular filtrate. As renal damage
progresses in hypercalcemic states, the amount of filtered calcium and hence the
amount of calcium appearing in the urine is frequently reduced. There is evidence
that complexed calcium is less readily reabsorbed in the renal tubules than is ionic
calcium since infusion of such complexing substances as citrate, sulfate and EDTA
greatly increases the urinary excretion of calcium. Current data suggests that parathyroid hormone increases tubular reabsorption of calcium. Hence, after the administration of parathyroid hormone the urinary excretion of calcium is initially
decreased and only later when hypercalcemia accounts for an increased filtered load
does the urinary calcium excretion increase. Following parathyroidectomy on the
other hand, urinary calcium is initially increased and only after the serum calcium
falls does the urinary excretion of calcium decrease. It has been stated that in
mildly hypercalcemic states a normal or reduced urinary calcium concentration supports the diagnosis of hyperparathyroidism over other causes of hypercalcemia. The
reliability of this thesis has not been fully tested. Vitamin D influences renal excretion
of calcium, especially when administered in large doses. In some instances, such
as in hypoparathyroidism, administration of vitamin D is followed by hypercalciuria
before elevation of the serum calcium occurs. Hence, the effectiveness of therapy
with vitamin D in hypoparathyroidism cannot be evaluated by the response in urinary
calcium alone. Solute diuresis, especially after intravenous sodium salts, enhances
urinary excretion of calcium and in many respects renal tubular handling of calcium
and sodium are parallel. Current evidence based on micropuncture techniques' indicates that most of the filtered calcium is reabsorbed in the proximal convoluted
tubules, but some reabsorption occurs in the distal tubules as well.
The determination of the 24 hour urine calcium is of value only if considered in
light of the total clinical and laboratory picture. There has been considerable disagreement as to the normal 24 hour urine calcium excretion value. This is due to
the fact that different authors have used varying degrees of dietary calcium restriction
during the test. In general, most normal subjects excrete less than 300 mgm. of
calcium per 24 hours on a diet of average calcium intake. When milk and other
dietary products are removed from the diet, urinary calcium excretion will generally
be less than 200 mgm. per 24 hours. I f a markedly restricted calcium intake of less
than 150 mgm. in 24 hours is taken, the urinary calcium excretion should then be
less than 150 mgm. per 24 hours. The patient as well as the nurse should be instructed
in the correct urine collection technique and also adequate urinary collection should
be confirmed by urinary creatinine determination. It is important to remember
that calcium salts may precipitate on the walls of the specimen bottle and thereby
falsely reduce the urinary calcium value. A small amount of concentrated acid added
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to the urine collection bottle will keep the urinary calcium in solution. However
this makes it more difficult for the laboratory in that the specimen then has to be
neutralized before the calcium determination is performed.
Determination of the urinary pH may be of help in the evaluation of renal
lithiasis, especially if the urine is free of infection. A persistently alkaline urine
should always raise the question of an underlying renal tubular defect such as renal
tubular acidosis. In this case hyperchloremic acidosis may be apparent from the
results of the serum electrolytes. In borderline cases, the ammonium chloride load
test may be used to determine whether there is a defect in the renal mechanisms for
handling an acid load. Ammonium chloride solution, . 1 gram per kilo, administered
in a palatable solution with observation of the urinary pH for 6-7 hours will help
define such cases. A decrease in the urinary pH below 5.5 indicates adequate renal
tubular mechanisms for urine acidification and virtually rules out renal tubular acidosis.
Measuring the hydrogen ion clearance index as proposed by Elkinton is a more refined
way of testing for renal tubular acidosis."
Determination of the 24 hour urine oxalate will be of help in the diagnosis of
the rare inborn error of metabolism oxalosis, which gives rise not only to repeated
calcium oxalate stones, but also tO' a general tissue deposition of calcium oxalate.'
In this instance, there is a persistent and excessive excretion of urinary oxalate
greater than 100 mgm. per 24 hours. It is to be remembered that calcium oxalate
nephrolithiasis is very common and most patients with such stones do not have a
metabolic error in oxalic acid metabolism. In these latter patients, the daily urinary
oxalate excretion is less than 50 mgm.
Table I I is a list of the more common causes of hypercalciuria that are to be
considered in the differential diagnosis of the patient with kidney stones and increased
calcium in the urine.
Table I I
Causes of Hypercalciuria
1. Hyperparathyroidism
2. Hyperthyroidism
3. Immobilization
4.

Osteoporosis (certain types)

5. Cushing's syndrome
6. Metastatic cancer, myeloma
7. Renal tubular acidosis
8. Fanconi syndrome
9. Vitamin D intoxication
10.

Sarcoidosis

11.

"Idiopathic" hypercalciuria

12.

Paget's disease
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It is important to remember that the urinary calcium concentration is only one
of many factors which determine whether or not a patient will have kidney stones.
Patients may have marked hypercalciuria for long periods without developing kidney
stones. On the other hand, there are many patients with normal urinary calcium
excretion who have repeated calcium nephrolithiasis.
In general, the determination of the urinary calcium excretion is not of much
help in the diagnosis of hyperparathyroidism since almost all conditions causing hypercalcemia also have associated hypercalciuria. An exception is the milk alkali syndrome
where, because of renal insufficiency, urinary calcium excretion is normal or decreased
despite hypercalcemia. Reduced calciuria also occurs in other hypercalcemic conditions after the development of significant renal failure. The hypercalciuria of
hyperthyroidism may be extreme, but seldom do such patients have nephrolithiasis.
The cause for this is not known. The calciuria in involutional osteoporosis is
variable, probably because there are many causes of osteoporosis and only certain
types are accompanied by increased urinary calcium excretion. The incidence of
kidney stones in patients with Cushing's disease has been a significant complication
in some series. In multiple myeloma and metastatic cancer the renal excretion of
calcium may be greatly increased, but rarely do these patients present with
kidney stones. Hypercalciuria in renal tubular acidosis is variable and does not seem
to be the determinant factor in the occurrence of kidney stones. The reduction
of urinary citrate that occurs in the syndrome may be an important consideration in this regard. The hypercalciuria in the Fanconi syndrome again may
be quite marked, but only occasionally are kidney stones a problem. Perhaps the
associated aminoaciduria present in the syndrome helps maintain calcium in solution
by enhancing chelation with amino acids.
There are several subclassifications of the entity known as idiopathic hypercalciuria which is frequently accompanied by recurrent nephrolithiasis and which may
be difficult to distinguish from hyperparathyroidism. In some instances, the hypercalciuria is accompanied by hypophosphatemia, but the serum calcium is normal.
Two separate theories have been postulated to explain idiopathic hypercalciuria. One
theory is a primary renal tubular defect for calcium resulting in hypercalciuria and
a tendency towards early hypocalcemia, which is then corrected by a secondary
hyperparathyroidism. The latter would account for the depression of serum phosphorus
often present in the condition. The other incriminates a hyperabsorption of calcium
from the intestinal tract and thence secondary hypercalciuria. Theoretically, one
would expect in the latter instance a depression of the parathyroid glands and an
increased serum inorganic phosphorus, but this does not occur. Nevertheless, evidence
obtained in balance studies after the administration of sodium phytate and cellulose
phosphate supports the contention that hyperabsorption of calcium may be an important
factor. Under these circumstances, fecal calcium is increased and urine calcium
decreased without the occurrence of a negative calcium balance.'" It has also been
demonstrated that certain of the newer diuretic agents such as bendrofluorazide
decreases urinary calcium excretion in patients with idiopathis hypercalciuria.'"" The
concurrent administration of both cellulose phosphate and bendrofluorazide is probabl)'
442

DIAGNOSIS

OF KIDNEY

STONES

the best present method of reducing urinary calcium excretion in patients with idiopathis hypercalcuria and recurrent nephrolithiasis.
U R I C A C I D STONES

The radiolucent renal stone is almost always composed of uric acid except for
the rare cases of glycinuria and xanthinuria. Metabolic evaluation in patients with
uric acid lithiasis brings into consideration many etiologic factors. The patient may
have classic gout or only a family history of gout. In the latter mstance, hyperuricemia
and also an increased urinary excretion of uric acid is usually present. The determination of both the serum and urinary uric acid may be misleading, especially if
the patient has been on salicylates or diuretic agents. Some patients with uric acid
lithiasis have hyperuricemia and hyperuricosuria without a past, personal or family
history of gout. Other family members may also have increased concentration of
uric acid in the serum and urine without evidence of gout. These patients are said
to have essential or idiopathic hyperuricemia. Uric acid Hthiasis may be a serious
problem in these patients and to protect the kidney against gouty nephropathy, they
should be treated with uricosuric agents as vigorously as if they had true gout.
There is also an increased incidence of uric acid stones in patients with chronic
enteritis and colitis.'" In this instance the diversion of water excretion to the bowel
results in a decreased urinary flow and a persistentiy acid p H of the urine which
predispose to uric acid lithiasis.
Not infrequently patients with uric acid lithiasis will have normal concentrations
of uric acid in the serum and urine. In this instance, a persistently acid p H of the
urine is frequently observed. It has ben postulated that these patients have a renal
tubular defect for effective urinary alkalinization which predisposes to uric acid
crystaUzation. It has been suggested that a defect in ammonia production by the
kidney in such patients may be an important limiting factor.
Patients with uric acid lithiasis should always be evaluated for underiying blood
dyscrasias such as leukemia, lymphoma and myeloproliferative disorders. Uric acid
stones are especially likely to occur following treatment of leukemia with various
antileukemic agents where there is an increased breakdown of nucleoprotein.
The traditional therapy of uric acid lithiasis has been fluid administration and
alkalinization of the urine. Administration of uricosuric agents such as benemid
may temporarily aggravate uric acid stone formation by an initial increase in uric
acid excretion. A recent new approach offers promising therapy for the future.
Allopurinol, a xanthine oxidase inhibitor, has been found to reduce synthesis of
uric acid and thereby reduce its urinary excretion. This therapy may be especially
helpful in those patients with gouty nephritis and ureteral obstruction from uric acid
crystallization. Allopurinol may be used in conjunction with other modes of therapy
including urinary alkalinization and uricosuric agents. One theoretic objection, that
has not been a problem to date, is that the increased urinary excretion of xanthine
occurring after the administration of Allopurinol may conceivably lead to increased
formation of xanthine stones.
443

FRAME
CYSTINURIA

A rare and interesting metabolic defect leading to nephrolithiasis is that of
cystinuria. A family history of nephrolithiasis and onset early in life should lead
one to suspect this diagnosis. The typical hexagonal crystals of cystine are readily
identifiable in the urinary sediment. Urinary chromatography may also be of help
in identifying the increased urinary excretion of not only cystine but also' other
dibasic amino acids such as lysine, glysine and ornithine. Recent evidence has thrown
some doubts upon the long accepted theory of a renal transport defect for cystine
in this condition. The renal tubular transport defect may actually involve cysteine
rather than cystine.'^
The time honored therapy for cystinuria has been similar to that for uric acid
lithiasis, mainly hydration and urinary alkalinization. Night time hydration has been
stressed as an important factor in prevention of cystine crystalization. Recentiy a
new approach to the treatment of cystinuria has been introduced." It has been
demonstrated that D-penicillamine can combine as a disulphide linkage with cysteine and
thence be excreated in the urine. Since D-penicillamine cysteine is more soluble than
cystine itself, cystine lithiasis is less likely to occur. At the present time, D-penicillamine
is an expensive mode of therapy, but perhaps production costs can be reduced. Also
other similar, but less expensive agents undoubtedly will be introduced. In some
instances, skin rash and signs of renal irritation have necessitated the discontinuance
of D-penicillamine."
UNUSUAL STONES

Silicate stones are common in cattle where there is an increased intake of sand
and dirt present in hay and other feed. The use of certain antacids such as magnesium
trisilicate have also been rarely reported to be associated with the formation of
silicate stones in man. The finding of silicate stones in the urine should also raise
the possibility of malingering. Such was the experience at this hospital several years
ago when a female patient brought in several small pebble-like stones that she
claimed she had passed in the urine. These stones proved to be calcium silicate by
x-ray diffraction and , when faced with the evidence, the patient admitted that she
had selected the stones from her driveway. She used the story of nephrolithiasis and
renal colic as a method of obtaining narcotics.
Rare instances of xanthine stones have been reported in the literature. As
mentioned previously, the use of Allopurinol in the treatment of uric acid lithiasis
may theoretically increase the tendency towards xanthine stone formation.
Rarely, renal tubular defects for other amino acids such as glycine have led
to formation of pure amino acid stones. These unusual conditions are best diagnosed
by the use of urinary paper or column chromatography. Rarely in the metabolic
defect alkaptinuria precipitation of the dark stones containing homogentisic acid
occurs in the urine.
In this discussion of nephrolithiasis the important factors of urinary obstruction
and infection have been omitted. These certainly complicate diagnosis and thera.py
but are major subjects in themselves.
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SUMMARY

The

corerct medical diagnosis of

kidney

stones requires the

cooperative effort of the internist, urologist and

clinical pathologist.

early will often give a clue to the metabolic error and
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renal insufficiency not

only simplifies investigation, but

definitive therapy in most instances.
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patient with kidney stones to submit to an early and adequate metabolic evaluation.
In the long run this will undoubtedly save the patient time, convenience and expense,
in addition
infection and
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chance of renal

insufficiency.

Treatment

of

pain,

obstruction in a patient with urinary tract stones without adequate

metabolic evaluation is to be condemned.
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